The current debate on the next EU Framework Programme for Research and Innovation (FP9) offers the opportunity to articulate a long-term vision for biomedical and health research, and to address current gaps in support of excellent science.
A European Union that ensures patient access and sustainability
Date
Address
Section
Event Location
Event Description
14h30 - Registration and welcome
15h00 - Welcome address
- Dr. Tibor STELBACZKY, Ambassador Plenipotentiary, Deputy Permanent Representative of Hungary to the European Union
15h05 - Keynote address
- Mr. Goran ŠTEFANIĆ, Ambassador Plenipotentiary, Deputy Permanent Representative of Croatia to the EU
15h10 - Keynote address
- Christoph Stoller, President Medicines for Europe
15h15 - Introductory speeches
- Breaking down silos for safe, effective and affordable medicines Sylvain Giraud - Head of Unit, Performance of national health systems, Directorate-General for Health and Food Safety, European Commission
- Access to pharmaceuticals in CEE: potential to fulfil unmet needs Zoltán Kaló - Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University
- The new Commission vision in ensuring equitable and sustainable access Olga Solomon - Head of Unit Medicines: policy, authorisation and monitoring, Directorate General for Health and Food Safety, European Commission
15h45 - PANEL I: Overcoming access barriers to oncology treatment
- Valerie Paris - Organisation for Economic Co-operation and Development (OECD)
- Zoltán Kaló - Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University
- Rosa Giuliani - Director of Public Policy, European Society of Medical Oncology (ESMO)
- Vera Pataki - Chair of the CEE Network, Medicines for Europe
- Beata Ambroziewicz - Board of the European Cancer Patient Coalition and President of Polish Union of Patient Organisations - (tbc)
16h45 - Coffee Break
17h00 - PANEL II: Maintaining generic medicines availability and preventing shortages
- Ilka Wölfle - President, European Social Insurance Platform
- Adrian van den Hoven - Director General, Medicines for Europe
- Stephanie Kohl - Policy and Advocacy Officer, European Association of Hospital Pharmacists (EAHP)
18h00 - Closing remarks
- Edina TÓTH - Member of the Environment, Public health and Food safety Committee of the European Parliament (EPP)
- Christoph Stoller - President Medicines for Europe Moderator all sessions: Aidan Fry, Stada and former editor at Informa (tbc)
18h50 - A cocktail reception will follow the seminar
Related Events
On Tuesday, March 20th, 2018, the Global Sepsis Alliance, jointly with EU Commissioner for Health and Food Safety, Vytenis Andriukaitis, will host the event 'Sepsis - The Most Prev
Big data is revolutionising healthcare and it is at our fingertip! Find out how to get onboard the movement that is fast transforming the way we live and work!
The European Cancer Patient Coalition, together with MEP Marlene Mizzi (S&D, Malta), is organising an event on the topic of Cancer Biomarkers in the Era of Personalised Medicines.
Ten years after the European Commission’s “White paper on a Strategy for Europe on Nutrition, Overweight and Obesity-related health issues”, the European Snacks Association gathers stakeholders to discuss the lessons learned and explore ways of building consensus on eff
There are currently over 200 million women living with diabetes and this total is projected to increase to more than 300 million by 2040. Diabetes is the ninth leading cause of death in women globally, causing 2.1 million deaths each year.
The Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) is hosting a seminar to assess the impact of the GDPR on FP9 health research and examine how the Code of Conduct for Health Research being developed by BBMRI-ERIC a
Hosted by MEP Heinz K. Becker (EPP, Austria)
European Policy Response to Metastatic Breast Cancer
Tuesday 17th October 2017, 12.00-14.00 CET
Consumer rights
Sustainable agriculture, safer food, strong rural communities
At the European Parliament in Brussels in room A3G-3.
On Wednesday 27 September 2017 from 14h30 - 17h30.
On the 20th of June 2017, Brussels will become the capital of Flavour.
Skin Cancer: Safe Work Under the Sun
The European Parliament Interest Group on Allergy and Asthma invites you to the policy symposium “United Action for Allergy and Asthma” at the Europea
“European policy response to rare cancers: the case of sarcoma”
8th February 2017, 14h30-16h30
European Parliament, Altiero Spinelli building, room A5E-2, Brussels
Pages
Events of the week
Jobs
EURACTIV News
- Political groups’ agreement on Health Commissioner Várhelyi leaves deep divisions
- ICC arrest warrant for Netanyahu ‘binding’ on all member states, says EU chief diplomat
- UK cuts €500 billion from defence budget, retires several major aircraft and ships
- Large capex investment needed for Europe’s district heating solutions, tailored approach preferred [Advocacy Lab Content]
- Universal access to diabetes care urgently needed in Europe, but political will is lacking [Advocacy Lab Content]